-
FDA advisory committees forgo restricting cough-cold sales, CHPA responds
WASHINGTON A pair of Food and Drug Administration advisory committees on Tuesday evening recommended that the FDA not place greater sales restrictions on the sale of dextromethorphan by placing the ingredient on the controlled substances schedule. The panel of FDA advisers voted to not schedule DXM by a vote of 15-9.
-
Study: Smoking cessation can provide health, economic benefits to Calif., nation
SACRAMENTO, Calif. A new study released Wednesday by the American Lung Association, and conducted by researchers at Penn State University, found that helping smokers quit not only saves lives but also offers favorable economic benefits to California and the nation.
“Smoking Cessation: The Economic Benefits” provides a nationwide cost-benefit analysis that compares the societal costs of smoking with the economic benefits of states providing cessation coverage.